Skip to main content

Reslizumab Side Effects

Medically reviewed by Drugs.com. Last updated on Mar 18, 2024.

Applies to reslizumab: intravenous solution.

Important warnings This medicine can cause some serious health issues

Intravenous route (solution)

Anaphylaxis has been observed with reslizumab infusion in 0.3% of patients in placebo-controlled clinical studies.

Anaphylaxis was reported as early as the second dose of reslizumab.

Anaphylaxis can be life-threatening.

Patients should be observed for an appropriate period of time after reslizumab administration by a healthcare professional prepared to manage anaphylaxis.

Discontinue reslizumab immediately if the patient experiences signs or symptoms of anaphylaxis.

Common side effects of reslizumab

Some side effects of reslizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common side effects

  • throat pain

Incidence not known

  • bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site

Serious side effects of reslizumab

Along with its needed effects, reslizumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking reslizumab:

Rare side effects

  • cough
  • difficulty with swallowing
  • dizziness
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fast heartbeat
  • hives, itching, or skin rash
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • redness of the skin
  • tightness in the chest
  • unusual tiredness or weakness

For healthcare professionals

Applies to reslizumab: intravenous solution.

Gastrointestinal adverse events

Hematologic

Hypersensitivity

Immunologic

Musculoskeletal

Oncologic

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics."

2. (2016) "Product Information. Cinqair (reslizumab)." Teva Pharmaceuticals USA

Further information

Reslizumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.